Claudio Laudani

891 total citations · 3 hit papers
40 papers, 420 citations indexed

About

Claudio Laudani is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Claudio Laudani has authored 40 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cardiology and Cardiovascular Medicine, 14 papers in Surgery and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Claudio Laudani's work include Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Acute Myocardial Infarction Research (14 papers) and Atrial Fibrillation Management and Outcomes (12 papers). Claudio Laudani is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (14 papers), Acute Myocardial Infarction Research (14 papers) and Atrial Fibrillation Management and Outcomes (12 papers). Claudio Laudani collaborates with scholars based in Italy, United States and Spain. Claudio Laudani's co-authors include Davide Capodanno, Antonio Greco, Marco Spagnolo, Giovanni Occhipinti, Carla Rochira, Maria Sara Mauro, Federica Agnello, Simone Finocchiaro, Placido Maria Mazzone and Denise Cristiana Faro and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Claudio Laudani

36 papers receiving 415 citations

Hit Papers

Pharmacology and Clinical Development of Factor XI Inhibi... 2023 2026 2024 2025 2023 2024 2025 25 50 75

Peers

Claudio Laudani
Claudio Laudani
Citations per year, relative to Claudio Laudani Claudio Laudani (= 1×) peers Maria Sara Mauro

Countries citing papers authored by Claudio Laudani

Since Specialization
Citations

This map shows the geographic impact of Claudio Laudani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claudio Laudani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claudio Laudani more than expected).

Fields of papers citing papers by Claudio Laudani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claudio Laudani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claudio Laudani. The network helps show where Claudio Laudani may publish in the future.

Co-authorship network of co-authors of Claudio Laudani

This figure shows the co-authorship network connecting the top 25 collaborators of Claudio Laudani. A scholar is included among the top collaborators of Claudio Laudani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claudio Laudani. Claudio Laudani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spagnolo, Marco, Daniele Giacoppo, Claudio Laudani, et al.. (2025). Advances in the Detection and Management of Vulnerable Coronary Plaques. Circulation Cardiovascular Interventions. 18(8). e015529–e015529. 3 indexed citations
2.
Greco, Antonio, Marco Spagnolo, Claudio Laudani, et al.. (2025). Targeting Inflammation After Acute Myocardial Infarction. Journal of the American College of Cardiology. 86(15). 1146–1169. 1 indexed citations
3.
Occhipinti, Giovanni, Claudio Laudani, Mattía Galli, et al.. (2025). Sex differences in dual antiplatelet therapy de-escalation strategies after percutaneous coronary intervention: a network meta-analysis. European Heart Journal. 2 indexed citations
4.
Laudani, Claudio, Antonio Abbate, Dominick J. Angiolillo, & Mattía Galli. (2025). CLEAR results, cloudy impact: colchicine's neutral role in ST-segment elevation myocardial infarction. European Heart Journal - Cardiovascular Pharmacotherapy. 11(3). 215–217. 6 indexed citations
5.
Galli, Mattía, Stefano Benenati, Claudio Laudani, et al.. (2025). Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists. Journal of the American College of Cardiology. 86(20). 1805–1819. 5 indexed citations
6.
Rinaldi, Riccardo, Michele Russo, Giovanni Occhipinti, et al.. (2025). Sex‐Related Differences in the Prognostic Role of Acetylcholine Provocation Testing. Journal of the American Heart Association. 14(5). e037942–e037942. 3 indexed citations
7.
Laudani, Claudio, Davide Capodanno, Felice Gragnano, et al.. (2025). Factor XI Inhibitors or Direct Oral Anticoagulants in Atrial Fibrillation: A Focused Meta-analysis. Thrombosis and Haemostasis. 1 indexed citations
8.
Spagnolo, Marco, Nicola Ammirabile, Giovanni Di Leo, et al.. (2025). Changes in Coagulation Factor XI Activity Levels in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI. Thrombosis and Haemostasis. 125(9). 893–904. 4 indexed citations
9.
Laudani, Claudio, Daniele Giacoppo, G. Occhipinti, et al.. (2025). Aspirin or P2Y12 Inhibitor Monotherapy After Percutaneous Coronary Intervention for Acute Coronary Syndromes. JACC: Cardiovascular Interventions. 18(15). 1848–1859. 2 indexed citations
10.
Laudani, Claudio, Giovanni Occhipinti, Antonio Greco, et al.. (2025). A pairwise and network meta-analysis of anti-inflammatory strategies after myocardial infarction: the TITIAN study. European Heart Journal - Cardiovascular Pharmacotherapy. 11(3). 218–229. 10 indexed citations
11.
Laudani, Claudio, et al.. (2025). Safety and optimal use of direct oral anticoagulant therapy. Expert Opinion on Drug Safety. 1–20.
13.
Pompei, Graziella, Christos P. Kotanidis, Claudio Laudani, et al.. (2024). Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysis. European Heart Journal Open. 4(6). oeae093–oeae093. 3 indexed citations
14.
Greco, Antonio, Marco Spagnolo, Claudio Laudani, et al.. (2024). Assessment of Noninferiority Margins in Cardiovascular Medicine Trials. JACC Advances. 3(7). 101021–101021. 8 indexed citations
15.
Spagnolo, Marco, Giovanni Occhipinti, Claudio Laudani, Antonio Greco, & Davide Capodanno. (2024). Periprocedural myocardial infarction and injury. European Heart Journal Acute Cardiovascular Care. 13(5). 433–445. 9 indexed citations
16.
Occhipinti, Giovanni, Claudio Laudani, Marco Spagnolo, et al.. (2024). Pharmacological and clinical appraisal of factor XI inhibitor drugs. European Heart Journal - Cardiovascular Pharmacotherapy. 10(3). 245–258. 19 indexed citations
17.
Galli, Mattía, Claudio Laudani, Giovanni Occhipinti, et al.. (2024). P2Y12 inhibitor monotherapy after short DAPT in acute coronary syndrome: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 10(7). 588–598. 18 indexed citations
18.
Spagnolo, Marco, Claudio Laudani, Antonio Greco, Daniele Giacoppo, & Davide Capodanno. (2024). Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine. American Journal of Cardiovascular Drugs. 24(5). 651–661. 1 indexed citations
19.
Spagnolo, Marco, Antonio Greco, Claudio Laudani, et al.. (2023). Asociación de las características del ensayo con la publicación simultánea y su impacto en citas y menciones: un estudio transversal. Revista Española de Cardiología. 77(4). 324–331. 1 indexed citations
20.
Greco, Antonio, Denise Cristiana Faro, Federica Agnello, et al.. (2023). Eligibility to Intensified Antithrombotic Regimens for Secondary Prevention in Patients Who Underwent Percutaneous Coronary Intervention. The American Journal of Cardiology. 199. 7–17. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026